Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Louis C. Bock currently holds 654 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis C. Bock has been a net buyer of OREX stock. They have purchased $18.1M and sold $2.4M worth of shares.
Louis C. Bock's most recent insider trade was on Mar 12, 2018, when they sold 218 shares at $32.00 per share.
Louis C. Bock serves as Executive at Orexigen Therapeutics, Inc. (OREX). They have executed 148 insider transactions totaling $20.5M over their tenure at the company.
Louis C. Bock holds the position of Executive at Orexigen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Louis C. Bock has shown a buying trading pattern, with $18.1M in total purchases and $2.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Louis C. Bock was on Aug 20, 2008, when they sold $7.6M worth of SGXP shares. This transaction involved 2,546,747 shares at $3.00 per share.
Louis C. Bock currently owns 654 shares of Orexigen Therapeutics, Inc. (OREX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Louis C. Bock's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Louis C. Bock has 148 Form 4 filings on record as an insider at Orexigen Therapeutics, Inc..
Set alerts for Louis C. Bock and 40,000+ other insiders.